Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Can-Fite commences phase I/II CF-102 trial in liver cancer

April 17, 2009

FDA accepts for review Vion's NDA for Onrigin in AML

April 17, 2009

Novel annelated pyridazines claimed by Amgen for cancer treatment

April 17, 2009

Takeda claims novel tyrosine kinase inhibitors

April 17, 2009

Pro-Pharmaceuticals' Davanat was not associated with mucositis in phase I and II trials

April 16, 2009

First human pharmacokinetic data for anticancer agent KP-1019 reported

April 16, 2009

Novel MEK inhibitors identified by Curis

April 16, 2009

Sanofi-aventis to acquire BiPar Sciences

April 15, 2009

FDA grants orphan drug designation for Paclical in ovarian cancer

April 15, 2009

Bayer describes novel substituted tricyclic compounds for cancer treatment

April 15, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...